96398 ⎘
Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals; Carbocyclic rings; Cyclohexane rings, substituted by nitrogen atoms; Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A
Sub-classes:SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS
#2SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS
#3Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
#4Novel Antibacterial 3"-Derivatives Of 4,6-Disubstituted 2,5-Dideoxystreptamine Aminoglycoside Antibiotics
#5Amphiphilic kanamycin compositions and methods
#6Chromatographic material having improved pH stability, method for preparation thereof and uses thereof
#7COMBINATORIAL ANTIBIOTIC DERIVATIVES BASED ON SUPRAMOLECULAR STRUCTURES
#8Amphiphilic aminoglycoside connexin hemichannel inhibitors
#9Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
#10Nitric oxide-releasing polyaminoglycosides as biodegradable antibacterial scaffolds and methods pertaining thereto
#11Transcriptome-wide design of selective, bioactive small molecules targeting RNA
#12Suppressors of Premature Termination Codons as Therapeutics and Methods for Their Use
#13CHROMATOGRAPHIC MATERIAL HAVING IMPROVED PH STABILITY, METHOD FOR PREPARATION THEREOF AND USES THEREOF
#14Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
#15Transcriptome-wide design of selective, bioactive small molecules targeting RNA
#16NOVEL AMINOGLYCOSIDE ANTIBIOTICS
#17Arbekacin derivative, and production and use thereof
#18Aminoglycosides, Methods of Synthesis, and Associated Applications
#19Kanamycin compound, kanamycin-producing species bacterium, and method of producing kanamycin
#20Selective oxidation of carbohydrates
#21Readthrough inducing agent and drug for treating genetic disease caused by nonsense mutation
#22Aqueous compositions comprising arbekacin
#23Anionic conjugates of glycosylated bacterial metabolite
#24Compounds for use in the treatment of bacterial infection
#25Aminoglycoside antibiotics
#264,6-substituted 2,5-dideoxystreptamine aminoglycoside antibiotics
#27Antibacterial 4,6-substituted 6′, 6″ and 1 modified aminoglycoside analogs
#28Readthrough Inducing Agent and Drug for Treating Genetic Disease Caused by Nonsense Mutation
#29Aminoglycosides: synthesis and use as antifungals
#30AMINOGLYCOSIDE DOSING REGIMENS
#31Aminoglycoside antibiotics
#32Antibacterial aminoglycoside analogs
#33Antibacterial aminoglycoside analogs
#34Antibacterial aminoglycoside analogs
#35Antibacterial 4,6-substituted 6′, 6″ and 1 modified aminoglycoside analogs
#36Anionic conjugates of glycosylated bacterial metabolite
#37Aminoglycosides: Synthesis and Use as Antifungals
#38Aminoglycoside antibiotics, process for producing the same, and pharmaceutical use thereof
#39Aminoglycoside antibiotics
#40Novel aminoglycoside antibiotics effective against methicillin resistant staphylococcus auerus (mrsas)
#41Novel chemical compounds and their use
#42Dimeric pharmaceutical compounds and their use
#43Oral absorbed drugs